The best of respiratory infections from the 2015 European respiratory society international congress

Eva Polverino, Graham H. Bothamley, Delia Goletti, Jan Heyckendorf, Giovanni Sotgiu, Stefano Aliberti

Research output: Contribution to journalArticle

Abstract

The breadth and quality of scientific presentations on clinical and translational research into respiratory infections at the 2015 European Respiratory Society (ERS) International Congress in Amsterdam, the Netherlands, establishes this area as one of the leadings fields in pulmonology. The host–pathogen relationship in chronic obstructive pulmonary disease, and the impact of comorbidities and chronic treatment on clinical outcomes in patients with pneumonia were studied. Various communications were dedicated to bronchiectasis and, in particular, to different prognostic and clinical aspects of this disease, including chronic infection with Pseudomonas and inhaled antibiotic therapy. Recent data from the World Health Organization showed that Europe has the highest number of multidrug-resistant tuberculosis cases and the poorest countries have the least access to suitable treatments. Latent tuberculosis and different screening programmes were also discussed with particular attention to risk factors such as HIV infection and diabetes. Several biomarkers were proposed to distinguish between active tuberculosis and latent infection. Major treatment trials were discussed (REMOX, RIFQUIN and STREAM). The possibility of once-weekly treatment in the continuation phase (RIAQUIN) was especially exciting. The continuing rise of Mycobacterium abscessus as a significant pathogen was noted. This article reviews some of the best contributions from the Respiratory Infections Assembly to the 2015 ERS International Congress.

Original languageEnglish
Article number00049-2016
JournalERS Monograph
Volume2
Issue number3
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Respiratory Tract Infections
Latent Tuberculosis
Therapeutics
Pseudomonas Infections
Multidrug-Resistant Tuberculosis
Pulmonary Medicine
Bronchiectasis
Translational Medical Research
Mycobacterium
Netherlands
Chronic Obstructive Pulmonary Disease
HIV Infections
Comorbidity
Pneumonia
Chronic Disease
Biomarkers
Communication
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The best of respiratory infections from the 2015 European respiratory society international congress. / Polverino, Eva; Bothamley, Graham H.; Goletti, Delia; Heyckendorf, Jan; Sotgiu, Giovanni; Aliberti, Stefano.

In: ERS Monograph, Vol. 2, No. 3, 00049-2016, 01.07.2016.

Research output: Contribution to journalArticle

Polverino, Eva ; Bothamley, Graham H. ; Goletti, Delia ; Heyckendorf, Jan ; Sotgiu, Giovanni ; Aliberti, Stefano. / The best of respiratory infections from the 2015 European respiratory society international congress. In: ERS Monograph. 2016 ; Vol. 2, No. 3.
@article{fe2f9f4eedaa44608b4c63ce5628975f,
title = "The best of respiratory infections from the 2015 European respiratory society international congress",
abstract = "The breadth and quality of scientific presentations on clinical and translational research into respiratory infections at the 2015 European Respiratory Society (ERS) International Congress in Amsterdam, the Netherlands, establishes this area as one of the leadings fields in pulmonology. The host–pathogen relationship in chronic obstructive pulmonary disease, and the impact of comorbidities and chronic treatment on clinical outcomes in patients with pneumonia were studied. Various communications were dedicated to bronchiectasis and, in particular, to different prognostic and clinical aspects of this disease, including chronic infection with Pseudomonas and inhaled antibiotic therapy. Recent data from the World Health Organization showed that Europe has the highest number of multidrug-resistant tuberculosis cases and the poorest countries have the least access to suitable treatments. Latent tuberculosis and different screening programmes were also discussed with particular attention to risk factors such as HIV infection and diabetes. Several biomarkers were proposed to distinguish between active tuberculosis and latent infection. Major treatment trials were discussed (REMOX, RIFQUIN and STREAM). The possibility of once-weekly treatment in the continuation phase (RIAQUIN) was especially exciting. The continuing rise of Mycobacterium abscessus as a significant pathogen was noted. This article reviews some of the best contributions from the Respiratory Infections Assembly to the 2015 ERS International Congress.",
author = "Eva Polverino and Bothamley, {Graham H.} and Delia Goletti and Jan Heyckendorf and Giovanni Sotgiu and Stefano Aliberti",
year = "2016",
month = "7",
day = "1",
doi = "10.1183/23120541.00049-2016",
language = "English",
volume = "2",
journal = "ERS Monograph",
issn = "2312-508X",
publisher = "European Respiratory Society",
number = "3",

}

TY - JOUR

T1 - The best of respiratory infections from the 2015 European respiratory society international congress

AU - Polverino, Eva

AU - Bothamley, Graham H.

AU - Goletti, Delia

AU - Heyckendorf, Jan

AU - Sotgiu, Giovanni

AU - Aliberti, Stefano

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The breadth and quality of scientific presentations on clinical and translational research into respiratory infections at the 2015 European Respiratory Society (ERS) International Congress in Amsterdam, the Netherlands, establishes this area as one of the leadings fields in pulmonology. The host–pathogen relationship in chronic obstructive pulmonary disease, and the impact of comorbidities and chronic treatment on clinical outcomes in patients with pneumonia were studied. Various communications were dedicated to bronchiectasis and, in particular, to different prognostic and clinical aspects of this disease, including chronic infection with Pseudomonas and inhaled antibiotic therapy. Recent data from the World Health Organization showed that Europe has the highest number of multidrug-resistant tuberculosis cases and the poorest countries have the least access to suitable treatments. Latent tuberculosis and different screening programmes were also discussed with particular attention to risk factors such as HIV infection and diabetes. Several biomarkers were proposed to distinguish between active tuberculosis and latent infection. Major treatment trials were discussed (REMOX, RIFQUIN and STREAM). The possibility of once-weekly treatment in the continuation phase (RIAQUIN) was especially exciting. The continuing rise of Mycobacterium abscessus as a significant pathogen was noted. This article reviews some of the best contributions from the Respiratory Infections Assembly to the 2015 ERS International Congress.

AB - The breadth and quality of scientific presentations on clinical and translational research into respiratory infections at the 2015 European Respiratory Society (ERS) International Congress in Amsterdam, the Netherlands, establishes this area as one of the leadings fields in pulmonology. The host–pathogen relationship in chronic obstructive pulmonary disease, and the impact of comorbidities and chronic treatment on clinical outcomes in patients with pneumonia were studied. Various communications were dedicated to bronchiectasis and, in particular, to different prognostic and clinical aspects of this disease, including chronic infection with Pseudomonas and inhaled antibiotic therapy. Recent data from the World Health Organization showed that Europe has the highest number of multidrug-resistant tuberculosis cases and the poorest countries have the least access to suitable treatments. Latent tuberculosis and different screening programmes were also discussed with particular attention to risk factors such as HIV infection and diabetes. Several biomarkers were proposed to distinguish between active tuberculosis and latent infection. Major treatment trials were discussed (REMOX, RIFQUIN and STREAM). The possibility of once-weekly treatment in the continuation phase (RIAQUIN) was especially exciting. The continuing rise of Mycobacterium abscessus as a significant pathogen was noted. This article reviews some of the best contributions from the Respiratory Infections Assembly to the 2015 ERS International Congress.

UR - http://www.scopus.com/inward/record.url?scp=84988474359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988474359&partnerID=8YFLogxK

U2 - 10.1183/23120541.00049-2016

DO - 10.1183/23120541.00049-2016

M3 - Article

VL - 2

JO - ERS Monograph

JF - ERS Monograph

SN - 2312-508X

IS - 3

M1 - 00049-2016

ER -